Osteoprotegerin in ST-elevation myocardial infarction: Prognostic impact and association with markers of myocardial damage by magnetic resonance imaging

International Journal of Cardiology

Volumn 167, Issue 5, 2013, Pages 2134-2139

  Fuernau, Georg ^a   Zaehringer, Sebastian ^a   Eitel, Ingo ^a   De Waha, Suzanne ^a   Droppa, Michal ^a   Desch, Steffen ^a   Schuler, Gerhard ^a   Adams, Volker ^a   Thiele, Holger ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Magnetic resonance imaging; Myocardial infarction; Osteoprotegerin; Prognosis; Reperfusion

Indexed keywords

ACETYLCYSTEINE; BIOLOGICAL MARKER; OSTEOPROTEGERIN; PLACEBO;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; HEART DEATH; HEART MUSCLE REPERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REPERFUSION INJURY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AAR; AREA AT RISK; CARDIAC MAGNETIC RESONANCE IMAGING; CI; CMR; CONFIDENCE INTERVAL; HAZARD RATIO; HR; INFARCT SIZE; IS; LEFT VENTRICULAR; LV; MACE; MAGNETIC RESONANCE IMAGING; MAJOR ADVERSE CARDIOVASCULAR EVENTS; MICROVASCULAR OBSTRUCTION; MO; MSI; MYOCARDIAL INFARCTION; MYOCARDIAL SALVAGE INDEX; OPG; OSTEOPROTEGERIN; PROGNOSIS; REPERFUSION; SINGLE PHOTON EMISSION TOMOGRAPHY; SPECT; ST-ELEVATION MYOCARDIAL INFARCTION; STEMI; THROMBOLYSIS IN MYOCARDIAL INFARCTION; TIMI;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; OSTEOPROTEGERIN; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS;

EID: 84883274295     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.05.101     Document Type: Article

References (34)

1. S. Jono, S. Otsuki, and Y. Higashikuni Serum osteoprotegerin levels and long-term prognosis in subjects with stable coronary artery disease J Thromb Haemost 8 2010 1170 1175
2. S. Jono, Y. Ikari, and A. Shioi Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease Circulation 106 2002 1192 1194
3. E.R. Pedersen, T. Ueland, and R. Seifert Serum osteoprotegerin levels and long-term prognosis in patients with stable angina pectoris Atherosclerosis 212 2010 644 649
4. T. Omland, T. Ueland, and A.M. Jansson Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes J Am Coll Cardiol 51 2008 627 633
5. A. Palazzuoli, R. Ascione, and M. Gallotta Osteoprotegerin and B-type natriuretic peptide in acute coronary syndromes with preserved systolic function: relation to coronary artery disease extension Int J Cardiol 137 2009 295 298
6. M.Y. Ren, S.J. Sui, and Y. Zhang Increased plasma osteoprotegerin levels are associated with the presence and severity of acute coronary syndrome Acta Cardiol 63 2008 615 622
7. A. Crisafulli, A. Micari, and D. Altavilla Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction Clin Sci (Lond) 109 2005 389 395
8. T. Ueland, R. Jemtland, and K. Godang Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction J Am Coll Cardiol 44 2004 1970 1976
9. G.O. Andersen, E.C. Knudsen, and P. Aukrust Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size Heart 97 2011 460 465
10. A. Erkol, S. Pala, and C. Kirma Relation of circulating osteoprotegerin levels on admission to microvascular obstruction after primary percutaneous coronary intervention Am J Cardiol 107 2011 857 862
11. M.G. Friedrich, H. Abdel-Aty, and A. Taylor The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance J Am Coll Cardiol 51 2008 1581 1587
12. S. de Waha, S. Desch, and I. Eitel Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers Eur Heart J 31 2010 2660 2668
13. I. Eitel, S. Desch, and G. Fuernau Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction J Am Coll Cardiol 55 2010 2470 2479
14. G. Fuernau, I. Eitel, and V. Franke Myocardium at risk in ST-segment elevation myocardial infarction comparison of T2-weighted edema imaging with the MR-assessed endocardial surface area and validation against angiographic scoring JACC Cardiovasc Imaging 4 2011 967 976
15. I. Eitel, S. Desch, and S. de Waha Long-term prognostic value of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction Heart 97 2011 2038 2045
16. E. Larose, J. Rodes-Cabau, and P. Pibarot Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance J Am Coll Cardiol 55 2010 2459 2469
17. H. Thiele, L. Hildebrand, and C. Schirdewahn Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial J Am Coll Cardiol 55 2010 2201 2209
18. J.A. Mohamed, H.L. DuPont, and Z.D. Jiang A single-nucleotide polymorphism in the gene encoding osteoprotegerin, an anti-inflammatory protein produced in response to infection with diarrheagenic Escherichia coli, is associated with an increased risk of nonsecretory bacterial diarrhea in North American travelers to Mexico J Infect Dis 199 2009 477 485
19. O.P. Simonetti, J.P. Finn, R.D. White, G. Laub, and D.A. Henry "Black blood" T2-weighted inversion-recovery MR imaging of the heart Radiology 199 1996 49 57
20. A.H. Aletras, G.S. Tilak, and A. Natanzon Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations Circulation 113 2006 1865 1870
21. H. Thiele, M.J. Kappl, and S. Conradi Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging J Am Coll Cardiol 47 2006 1641 1645
22. S. Desch, H. Engelhardt, and J. Meissner Reliability of myocardial salvage assessment by cardiac magnetic resonance imaging in acute reperfused myocardial infarction Int J Cardiovasc Imaging 28 2 2012 263 272
23. H. Thiele, K. Schindler, and J. Friedenberger Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial Circulation 118 2008 49 57
24. I. Eitel, K. Kubusch, and O. Strohm Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation-myocardial infarction Circ Cardiovasc Imaging 4 2011 354 362
25. L. Dong-bao, H. Qi, L. Zhi, W. Shan, and J. Wei-ying Predictors and long-term prognosis of angiographic slow/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction Clin Cardiol 33 2010 E7 E12
26. R. Roysland, S. Masson, and T. Omland Prognostic value of osteoprotegerin in chronic heart failure: the GISSI-HF trial Am Heart J 160 2010 286 293
27. S.M. Venuraju, A. Yerramasu, R. Corder, and A. Lahiri Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity J Am Coll Cardiol 55 2010 2049 2061
28. O.G. Shaker, A. El-Shehaby, and M. Nabih Possible role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as markers of plaque instability in coronary artery disease Angiology 61 2010 756 762
29. J.Y. Shin, Y.G. Shin, and C.H. Chung Elevated serum osteoprotegerin levels are associated with vascular endothelial dysfunction in type 2 diabetes Diabetes Care 29 2006 1664 1666
30. G.D. Xiang, H.L. Sun, and L.S. Zhao Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients Zhonghua Yi Xue Za Zhi 87 2007 1234 1237
31. S.H. Mangan, C.A. Van, C. Rush, and J. Golledge Osteoprotegerin upregulates endothelial cell adhesion molecule response to tumor necrosis factor-alpha associated with induction of angiopoietin-2 Cardiovasc Res 76 2007 494 505
32. D.M. Yellon, and D.J. Hausenloy Myocardial reperfusion injury N Engl J Med 357 2007 1121 1135
33. J. Vinten-Johansen Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury Cardiovasc Res 61 2004 481 497
34. M. Mesquita, A. Demulder, and N. Damry Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease Clin Chem Lab Med 47 2009 339 346